A detailed history of Concourse Financial Group Securities, Inc. transactions in Royalty Pharma PLC stock. As of the latest transaction made, Concourse Financial Group Securities, Inc. holds 326 shares of RPRX stock, worth $9,046. This represents 0.0% of its overall portfolio holdings.

Number of Shares
326
Previous 501 34.93%
Holding current value
$9,046
Previous $15,000 46.67%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 23, 2024

SELL
$26.26 - $29.9 $4,595 - $5,232
-175 Reduced 34.93%
326 $8,000
Q1 2024

Apr 30, 2024

SELL
$27.46 - $31.33 $961 - $1,096
-35 Reduced 6.53%
501 $15,000
Q4 2023

Feb 07, 2024

BUY
$26.21 - $29.22 $3,983 - $4,441
152 Added 39.58%
536 $15,000
Q3 2023

Oct 25, 2023

BUY
$26.26 - $31.38 $3,387 - $4,048
129 Added 50.59%
384 $10,000
Q2 2023

Aug 10, 2023

BUY
$29.6 - $36.56 $1,776 - $2,193
60 Added 30.77%
255 $7,000
Q1 2023

May 15, 2023

BUY
$32.77 - $39.4 $6,390 - $7,683
195 New
195 $7,000
Q4 2022

Jan 30, 2023

BUY
$39.17 - $44.04 $0 - $0
0 New
0 $0
Q3 2022

Nov 15, 2022

BUY
$39.88 - $44.65 $0 - $0
0 New
0 $0
Q2 2022

Aug 09, 2022

BUY
$37.53 - $44.22 $0 - $0
0 New
0 $0
Q1 2022

May 09, 2022

BUY
$37.46 - $42.44 $0 - $0
0 New
0 $0
Q4 2021

Feb 07, 2022

BUY
$35.17 - $42.48 $0 - $0
0 New
0 $0
Q3 2021

Nov 09, 2021

BUY
$36.14 - $42.24 $0 - $0
0 New
0 $0
Q2 2021

Aug 13, 2021

BUY
$39.85 - $46.63 $0 - $0
0 New
0 $0
Q1 2021

May 13, 2021

BUY
$42.34 - $52.82 $0 - $0
0 New
0 $0
Q4 2020

Feb 02, 2021

BUY
$36.12 - $50.05 $0 - $0
0 New
0 $0
Q3 2020

Nov 13, 2020

SELL
$38.56 - $48.36 $3,856 - $4,836
-100 Closed
0 $0
Q2 2020

Aug 13, 2020

BUY
$44.5 - $52.11 $4,450 - $5,211
100 New
100 $5,000

Others Institutions Holding RPRX

About Royalty Pharma plc


  • Ticker RPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 437,139,008
  • Market Cap $12.1B
  • Description
  • Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...
More about RPRX
Track This Portfolio

Track Concourse Financial Group Securities, Inc. Portfolio

Follow Concourse Financial Group Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.